Skip to content

Clinical study of extracorporeal shock wave combined with hip-preserving drugs for steroid-induced osteonecrosis of the femoral head

Clinical study of extracorporeal shock wave combined with hip-preserving drugs for steroid-induced osteonecrosis of the femoral head

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016283
Enrollment
Unknown
Registered
2018-05-24
Start date
2018-06-01
Completion date
Unknown
Last updated
2018-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteonecrosis of the femoral head

Interventions

A:Extracorporeal shock wave combined with hip-preserving drugs

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Aged from 18 to 65 years. To be expected to use corticosteroid hormones in large doses.

Exclusion criteria

Exclusion criteria: 1. The primary disease is heavier and is not suitable for participation in this study; 2. Those diagnosed with femoral head necrosis before enrollment; 3. Pregnant or lactating women; 4. allergies and allergies to a variety of drugs; 5. With severe heart, cerebrovascular disease, liver, renal insufficiency (hepatic function test ALT or AST more than 2 times the upper limit of normal, renal function tests creatinine or urea nitrogen exceed the upper limit of normal value), hematopoietic system diseases, severe gastrointestinal diseases , mental and central nervous system patients with severe underlying diseases; 6. Have bleeding tendency or vascular insufficiency; 7. Not suitable for MRI exams (clausia, with pacemakers, metal rings, etc.); 8. The researcher thinks it is not suitable to participate in other situations of this study.

Design outcomes

Primary

MeasureTime frame
The incidence of femoral head necrosis.;

Countries

China

Contacts

Public ContactFuqiang Gao

China-Japan Friendship Hospital

18901267995@163.com+86 18901267995

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026